Skip to main content
Lucy Godley, MD, Oncology, Chicago, IL, University of Chicago Medical Center

LucyAGodleyMDPhD(She/Her)

Oncology Chicago, IL

Hematologic Oncology

Professor of Medicine, Northwestern University

Dr. Godley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Godley's full profile

Already have an account?

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 1999 - 2003
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1997 - 1999
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1997

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2022 - 2026
  • IA State Medical License
    IA State Medical License 2021 - 2026
  • IL State Medical License
    IL State Medical License 1997 - 2026
  • TX State Medical License
    TX State Medical License 2022 - 2025
  • IN State Medical License
    IN State Medical License 2023 - 2025
  • CO State Medical License
    CO State Medical License 2021 - 2025
  • WI State Medical License
    WI State Medical License 2021 - 2023
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Elected Member The American Society for Clinical Investigation, 2012
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Feasibility and Outcomes of T-Cell Depleted Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML and High Risk MDS
    Lucy A Godley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • New Germline Syndrome Discovery: Heterozygous CSF3R Mutations May Predispose to Myeloid and Lymphoid Malignancies
    Lucy A. Godley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Deleterious Germline Variants, Especially in the DNA Repair Pathway, Are Common in Patients with Non-Related Multiple Cancers, One of Them Being Hematological Malignancy
    Lucy A. Godley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Friday Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Application of Microarray and Large Datasets to Hematology and Bioinformatics 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Inherited Hematopoietic Malignancies 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Press Mentions

  • 203 UChicago Medicine Doctors Named to 2022 Top Docs List
    203 UChicago Medicine Doctors Named to 2022 Top Docs ListJanuary 21st, 2022
  • Under Certain Conditions, Bacterial Signals Set the Stage for Leukemia
    Under Certain Conditions, Bacterial Signals Set the Stage for LeukemiaMay 14th, 2018
  • ASH Announces Partnership with UNC to Curate Genomic Data for Blood Disease Research
    ASH Announces Partnership with UNC to Curate Genomic Data for Blood Disease ResearchApril 6th, 2018

Grant Support

  • The Role Of DNMT3B In The DNA Methylation Of Cancer CellsNational Cancer Institute2008–2012
  • Epigenetic And Genetic Dissection Of Drug ResponseNational Human Genome Research Institute2011
  • A Chemical Crosslinking Strategy To Determine DNA Methylating Protein ComplexesNational Cancer Institute2009–2010

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations